Lenskart Solutions Limited Q2 FY26 Concall Decoded: 25% growth, AI everywhere, and Peyush’s billion-eyes obsession

1. Opening Hook

While India argues about screen time ruining eyesight, Lenskart quietly turned it into a growth engine. Peyush Bansal didn’t sound like a listed-company CEO defending quarterly margins—he sounded like a man on a decade-long mission to fix India’s vision problem, one eye test at a time.

This concall wasn’t about discount wars or festive season footfalls. It was about market creation, AI-driven compounding, and why opening two stores opposite each other actually increases demand. Yes, opposite each other.

Margins expanded, PAT nearly doubled, and AI somehow found its way into optometry, logistics, hiring, and even interviews. If you expected a boring post-IPO earnings call, this one had far more ambition than spreadsheets.

Read on. The real story is not eyewear—it’s scale, data, and operating leverage wearing glasses.

2. At a Glance

• Revenue up 24–25% – Growth without festive crutches.
• EBITDA margin 19.8% – Operating leverage finally flexing.
• PAT up 98% (H1) – Profits woke up violently.
• Product margin 69.2% – Vertical integration doing the heavy lifting.
• 450+ stores planned in FY26 – Cannibalization fears politely ignored.

3. Management’s Key Commentary

“We are not participating in the market; we are creating it.”
(Translation: TAM is what we say it is 😏)

“46% of eye tests were first-time users.”
(Demand was always there—nobody bothered unlocking it.)

“We have less than 5% market share in India.”
(Plenty of runway, no need to sprint yet.)

“Technology solves where to open stores, how to scale eye testing, and how to deliver.”
(AI now does what gut feel used to do, but better 🤖)

“Store-level EBITDA in India is ~33%.”
(Unit economics that private equity dreams of.)

“We are building a global compounding machine.”
(Not a chain, a flywheel.)

4. Numbers Decoded